Lieselot Croes

541 citations
15 papers · 379 indexed · h-index 8
Topics
Cancer Immunotherapy and Biomarkers (6 papers)Chemotherapy-induced cardiotoxicity and mitigation (5 papers)Epigenetics and DNA Methylation (3 papers)

In The Last Decade

Lieselot Croes

15 papers receiving 373 citations

Peers

Lieselot Croes
Comparison fields: 5 of 48
  • Molecular Biology 310
  • Immunology 114
  • Pulmonary and Respiratory Medicine 74
  • Oncology 73
  • Nephrology 67
Replace Kathleen R Bashant with:
Kathleen R Bashant United States
Øystein Eikrem Norway
Katja Möller‐Hackbarth Sweden
Xiaolan Lu China
Albin Björk Sweden
Yeqing Zou China
Li Zheng China
Louis Marois Canada
Shuya Kaneko Japan
Jordan Loeliger Switzerland
Lieselot Croes relative to Kathleen R Bashant United States Kathleen R Bashant's profile →
Citations per field
00.5×3.6×
Kathleen R Bashant · 1×
Citations per year

Countries citing papers authored by Lieselot Croes

Since Specialization
Citations

This map shows the geographic impact of Lieselot Croes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieselot Croes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieselot Croes more than expected).

Fields of papers citing papers by Lieselot Croes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lieselot Croes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieselot Croes. The network helps show where Lieselot Croes may publish in the future.

Co-authorship network of co-authors of Lieselot Croes

This figure shows the co-authorship network connecting the top 25 collaborators of Lieselot Croes. A scholar is included among the top collaborators of Lieselot Croes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lieselot Croes. Lieselot Croes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 2
2 1
3 4
4 2
5 7
6 6
7 26
8 5
9 72
10 64
11 31
12 91
13 40
14 3
15 25

About Lieselot Croes

Lieselot Croes is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Sensory Systems, having authored 15 papers that have together received 379 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Nephrology (67 citations), Immunology (114 citations) and Molecular Biology (310 citations). Lieselot Croes has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Ken Op de Beeck, Guy Van Camp, Marc Peeters, Patrick Pauwels, Joe Ibrahim, Erik Fransén, Wim Vanden Berghe, Arvid Suls, Matthias Beyens and Peter Vandenabeele. Their work appears in journals such as Annals of Oncology, International Journal of Cancer and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026